Chief Executive Officer

Magnus has a Master of Science degree in Engineering Biology from Linköping University. After graduation in 1999, Magnus has been working in various companies in the pharmaceutical industry. During the early years, work focused on fermentation and downstream processing of human growth hormone. Extensive work has also been around tech transfer and scale-up from R&D to production. Thereafter, Magnus managed several jobs related to validation of facilities, equipment, and processes for different pharmaceutical products. The latter part of the career focused on process development, production, and supply chain management. Recently, Magnus was Managing Director and site lead for a biotech company in Uppsala. To summarize, Magnus has close to 25 years’ experience from the pharmaceutical industry including GMP manufacturing. Currently, Magnus is conducting a MBA program at Edinburgh Business School.

Magnus joined the TdB Labs team in September 2024 as Chief Executive Officer.

Chairman of the Board

With a background of more than 30 years in the biotech supply, diagnostic, and med tech industry, Camilla has extensive experience gained in commercial, marketing management and executive roles. She has acquired her business understanding from managerial, strategic and operational positions in start-ups as well as global companies. She is appreciated as a business coach for life science companies and her skills include commercialization strategies, market positioning and overall business development.

Camilla today works with business consulting and diverse board assignments. She has completed several programs at Styrelseakademin.

Board Member, Owner 

Charlotte received her BSc in Physiotherapy in 1996 and worked at the Department of Neurology, Akademiska Sjukhuset, Uppsala University Hospital. From 2008 until 2014 she worked as a Lecturer in Physiotherapy at the Department of Neuroscience, Uppsala University. In 2009 she became Chief Executive Officer and has ever since taken the company and her own business skills through one of the world’s best business incubators, Uppsala Innovation Center, and successfully completed a mini-MBA program. She worked in close collaboration with highly skilled professionals in business economy, sales, marketing, and quality assurance, and led the company from a GLP level to ISO 9001 certification in 2015. Charlotte has in 2018 become a certified coach through the International Coach Federation and her efforts have generated a sustainable leadership and business model for TdB Labs with the help of Sweden´s most active business developer, ALMI. In 2023 she completed an investor education led by Connect and Life Science Invest.

Charlotte has throughout the most recent years completed professional education in Board strategy and sustainable Board Work. In 2024 she successfully completed Styrelseakademin’s program and became a certified Board member.

During her years TdB Labs has won several prizes and awards. In 2023 TdB Labs won the prestigious award “Small Business of the Year”.

Board Member 

Paul Alhadeff (B.Sc.) has more than three decades of experience in the pharmaceutical industry with companies like Pharmacia, AstraZeneca, and Syntagon/Ardena, where he has been instrumental in driving the technology transfer process of API manufacturing from R&D to production scale, bringing several new drugs to the market, and also outsourcing several processes.

In 1998, Paul co-founded the Contract Development Manufacturing Organization (CDMO) Syntagon/Ardena in Södertälje, where he serves as the Business Development Director Nordic Region since 2018. Currently, he also operates the CMC at some pharmaceutical development companies since 2012. During the years, Paul has managed to build his experience portfolio in the development and manufacturing of small molecules as well as more diverse APIs (eg: natural polymers and extracts from animal and vegetable origin), oligonucleotides and live bacteria that are used as active components in the dietary supplement and intended for pharmaceutical use.